Drugs / Fluvic HA syringe®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02592486 Comparator | Nov 2015 → Mar 2016 | bacterial pneumonia, influenza | Kameda Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluvic HA syringe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02592486 ↗ |
| Modality | Vaccine | “quadrivalent influenza vaccine” NCT02592486 ↗ |
| Route | Other | “The subjects receive injections of pneumococcal vaccine and influenza vaccine simultaneously.” NCT02592486 ↗ |